Introduction: The detection of inborn errors of metabolism (IEM), endocrinopathies, hemoglobinopathies, and other disorders through newborn screening (NBS) is a global health initiative that began until 1973 in Mexico. The national incidence of this group of diseases is uncertain due to the lack of NBS programs and related publications. For the present manuscript, the incidence of a specific group of IEM, endocrinopathies, hemoglobinopathies, and other disorders in newborns was estimated from an NBS program implemented in a private group of hospitals part of Grupo Christus Muguerza located northeast of Mexico.
|Acta Pediatrica Española
|Published - 4 abr 2020